Avience Biomedicals IPO
Medical Diagnostics & Healthcare Consumables - Listed on 25 June 2026
Avience Biomedicals IPO listing summary
Avience Biomedicals (Medical Diagnostics & Healthcare Consumables) closed its IPO window in 2026 and listed on NSE and BSE on 25 June 2026 at an upper band issue price of Rs 196, opening at Rs 277.6 for a listing gain of +41.6%. The IPO was subscribed - overall - QIB -, HNI/NII -, Retail -. The total issue size was Rs 30.24 Cr (Fresh Issue Rs 30.24 Cr, OFS Rs 0 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Listing day performance
Subscription breakdown
Final (Day 3) subscription
Number of times each investor category subscribed by close of Day 3.
Day-wise overall subscription
How overall subscription built up across the three-day issue window.
Avience Biomedicals IPO GMP history
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | - | - |
| Day 2 | - | - |
| Day 3 | - | - |
| Day 4 | - | - |
| Day 5 | - | - |
Issue & financials
Market context at listing
How the broader market moved around the Avience Biomedicals IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Avience Biomedicals IPO - FAQs
What was the listing gain of Avience Biomedicals IPO?
Avience Biomedicals IPO listed at +41.6% versus the upper issue price of Rs 196 on 25 June 2026.
How many times was Avience Biomedicals IPO subscribed?
Subscription data is listed in the Subscription breakdown section above.
What was the IPO GMP for Avience Biomedicals?
Day-by-day IPO GMP data for Avience Biomedicals is listed in the table above.